LRRK2 and Parkinson disease: Overall, these results indicated that the two LRRK2 G2019S-PD patients were very distinct, with the Mut1 patient showing a more advanced PD stage with motor and cognitive decline than Mut2, indicating involvement of several neuronal cell populations.